These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of the antimycobacterial compound 2-phenoxy-1-phenylethanone on rat hepatocytes and formation of metabolites. Rodrigues Coutinho AP; de Moraes LA; Barata LE; de Souza AO Pharm Biol; 2012 Oct; 50(10):1317-25. PubMed ID: 22857008 [TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064 [TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors. Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902 [TBL] [Abstract][Full Text] [Related]
5. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107 [TBL] [Abstract][Full Text] [Related]
6. Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles. Minarini PR; de Souza AO; Soares EG; Barata LE; Silva CL; Bentley MV Drug Dev Ind Pharm; 2012 Mar; 38(3):259-63. PubMed ID: 21854223 [TBL] [Abstract][Full Text] [Related]
7. Zanthoxylum capense constituents with antimycobacterial activity against Mycobacterium tuberculosis in vitro and ex vivo within human macrophages. Luo X; Pires D; Aínsa JA; Gracia B; Duarte N; Mulhovo S; Anes E; Ferreira MJ J Ethnopharmacol; 2013 Mar; 146(1):417-22. PubMed ID: 23337743 [TBL] [Abstract][Full Text] [Related]
8. Antimycobacterial activity of bacteriocins and their complexes with liposomes. Sosunov V; Mischenko V; Eruslanov B; Svetoch E; Shakina Y; Stern N; Majorov K; Sorokoumova G; Selishcheva A; Apt A J Antimicrob Chemother; 2007 May; 59(5):919-25. PubMed ID: 17347179 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of some novel 2-substituted-5-[isopropylthiazole] clubbed 1,2,4-triazole and 1,3,4-oxadiazoles as potential antimicrobial and antitubercular agents. Suresh Kumar GV; Rajendraprasad Y; Mallikarjuna BP; Chandrashekar SM; Kistayya C Eur J Med Chem; 2010 May; 45(5):2063-74. PubMed ID: 20149496 [TBL] [Abstract][Full Text] [Related]
10. Biological evaluation of bisbenzaldehydes against four Mycobacterium species. Cappoen D; Forge D; Vercammen F; Mathys V; Kiass M; Roupie V; Anthonissen R; Verschaeve L; Vanden Eynde JJ; Huygen K Eur J Med Chem; 2013 May; 63():731-8. PubMed ID: 23567963 [TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological activity, and SAR of antimycobacterial 9-aryl-, 9-arylsulfonyl-, and 9-benzyl-6-(2-furyl)purines. Bakkestuen AK; Gundersen LL; Utenova BT J Med Chem; 2005 Apr; 48(7):2710-23. PubMed ID: 15801862 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs. Braendvang M; Bakken V; Gundersen LL Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890 [TBL] [Abstract][Full Text] [Related]
14. Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety. Foroumadi A; Soltani F; Mirzaei M Pharmazie; 2003 May; 58(5):347-8. PubMed ID: 12779054 [TBL] [Abstract][Full Text] [Related]
15. Antimycobacterial activity of diphenylpyraline derivatives. Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832 [TBL] [Abstract][Full Text] [Related]
16. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: anti-Mycobacterium tuberculosis activity and cytotoxicity. Pavan FR; da S Maia PI; Leite SR; Deflon VM; Batista AA; Sato DN; Franzblau SG; Leite CQ Eur J Med Chem; 2010 May; 45(5):1898-905. PubMed ID: 20163897 [TBL] [Abstract][Full Text] [Related]
17. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies. Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336 [TBL] [Abstract][Full Text] [Related]
18. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis. Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370 [TBL] [Abstract][Full Text] [Related]
19. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo. Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635 [TBL] [Abstract][Full Text] [Related]
20. Antituberculosis agents. III. In vitro evaluation of antimycobacterial activity and cytotoxicity of some N-piperazinyl quinolone derivatives. Foroumadi A; Soltani F; Emami S; Davood A Boll Chim Farm; 2002; 141(3):247-9. PubMed ID: 12197426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]